Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
MC2-25
/
MC2 Therap
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
MC2-25
/
MC2 Therap
Journal:
Quantification of P-glycoprotein function at the human blood-brain barrier using [F]MC225 and PET.
(Pubmed Central) - Aug 8, 2023
[F]MC225 V, derived using a reversible two-tissue compartment model, is the preferred parameter to describe P-gp function in the human BBB. This outcome parameter has an average test-retest variability of 28%.
||||
||||||
MC2-25
/
MC2 Therap
New P2 trial:
The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
(clinicaltrials.gov) - Aug 1, 2022
P2
, N=108, Recruiting,
Sponsor: MC2 Therapeutics